Porcine FAD-containing monooxygenase metabolizes lidocaine, bupivacaine and propranolol in vitro.
Lidocaine, bupivacaine and propranolol are amines that can be expected to act as substrates for FAD-containing monooxygensae (FMO) (EC 1. 14. 13. 8). We found that FMO metabolizes lidocaine, bupivacaine and propranolol. The Km and Vmax values of lidocaine, bupivacaine and propranolol for FMO are 143, 408 and 210 microM, and 145, 119 and 135 nmol/min/mg FMO protein, respectively. The lipophilicity of the drugs decreased in the following order: lidocaine>propranolol>bupivacaine, under our experimental conditions. Furthermore, the metabolic products of FMO were separated by high-performance liquid chromatography and analyzed by gas chromatography-mass spectrometry, and were found to be the N-oxides and N-hydroxylamines of the respective drugs. These findings suggest that lidocaine, bupivacaine and propranolol are substrates for FMO, and the enzymatic toward lidocaine or bupivacaine may be inhibited exclusively and competitively by propranolol.
Wu
Ru Feng
RF
University of Texas Southwestern and Dallas Veterans Affairs Medical Center, Box 151, 4500 S. Lancaster Rd., Dallas, TX 75216, USA. rufengwu@yahoo.com
Liao
Cheng Xu
CX
Tomita
Shuhei
S
Ichikawa
Yoshiyuki
Y
Terada
Lance S
LS
D000818:Animals; D002045:Bupivacaine / Q000378:metabolism*; D002851:Chromatography, High Pressure Liquid; D005260:Female; D008012:Lidocaine / Q000378:metabolism*; D008862:Microsomes, Liver / Q000201:enzymology; D010105:Oxygenases / Q000502:physiology*; D011433:Propranolol / Q000378:metabolism*; D012995:Solubility; D013552:Swine
D008012:Lidocaine; D011433:Propranolol; D010105:Oxygenases; C020066:dimethylaniline monooxygenase (N-oxide forming); D002045:Bupivacaine